Overview

Sorafenib (Sorafenat) 200 mg tablets remain a high-volume oncology staple, and for B2B buyers the real differentiator is procurement discipline: minimum order quantities, handling and supply continuity. With broad approved use in hepatocellular carcinoma, renal cell carcinoma and thyroid cancer, sourcing strategy rather than novel mechanism is what protects treatment continuity. This guide focuses on the buying and logistics decisions that matter.

How It Works

Sorafenib is a multi-kinase inhibitor that simultaneously blocks Raf serine-threonine kinases and the VEGFR and PDGFR receptor tyrosine kinases. This dual action suppresses both the proliferative RAF-MEK-ERK cascade and the tumor's blood supply through anti-angiogenic effects. Although the molecular profile is well established, the commercial reality for distributors is steady, large-scale demand across several indications rather than niche targeting. Buyers should treat sorafenib as a continuity-critical product where availability outweighs novelty.

Indications

Sorafenib is indicated for advanced hepatocellular carcinoma, advanced renal cell carcinoma and differentiated thyroid carcinoma refractory to radioactive iodine. Its multi-indication status generates consistent reorder volume. Procurement teams should anticipate recurring demand from oncology and hepatology channels and size inventories to avoid stockouts that interrupt long-term oral therapy.

Dosage & Administration

The listed presentation is 200 mg film-coated tablets supplied 120 tablets per box, supporting the standard twice-daily oral regimen. Tablets are taken on an empty stomach with water and must be swallowed whole. Buyers should verify the 200 mg strength and count per box, because the 120-tablet pack is sized for a defined treatment cycle and mismatched packaging disrupts dispensing.

Storage & Sourcing

Store below 30 °C, in the original packaging, away from moisture and direct light; avoid freezing. As a widely sourced generic, sorafenib carries elevated counterfeit exposure, so authentication is essential. Buyers should procure from licensed manufacturers such as Natco, require GMP certificates and certificates of analysis, confirm batch traceability, and negotiate MOQ and lead times that protect uninterrupted supply across multiple indications.

FAQ

Q: What should buyers prioritize when sourcing sorafenib at scale? Authenticity and continuity. Require GMP and analysis certificates, verify batch traceability, and secure MOQ and lead times that prevent stockouts across HCC, RCC and thyroid indications.

Q: Does packaging format affect procurement planning? Yes. The 120-tablet box aligns with the standard oral cycle, so matching count and 200 mg strength to regimen avoids dispensing errors and waste.

Q: How should storage protect product quality during transit? Keep below 30 °C, dry and light-protected. Although sorafenib is not cold-chain mandated, controlled transit still safeguards potency.